Literature DB >> 21888492

A psychometric evaluation of the Hospital Anxiety and Depression Scale during pregnancy.

Gk Karimova1, Cr Martin.   

Abstract

The utility of the Hospital Anxiety and Depression Scale (HADS) as a screening instrument for anxiety and depression during pregnancy was investigated. A maximum likelihood factor analysis was conducted on the HADS to determine its psychometric properties and utility in 100 women from two culturally diverse populations (UK and Uzbekistan) at 12-weeks and 34-weeks pregnancy. The findings suggest that the HADS lacks the internal reliability requirements of a clinical assessment tool in this population. There was little evidence found to suggest that the HADS measures two dimensions of anxiety and depression consistently and reliably. The findings from this study suggest that the HADS could not be recommended as a clinical screening tool for anxiety and depression in pregnant women. Further research in this area is both desirable and required.

Entities:  

Year:  2003        PMID: 21888492     DOI: 10.1080/1354850021000059296

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  12 in total

1.  Construct Validity and Responsiveness of Instruments Measuring Depression and Anxiety in Pregnancy: A Comparison of EPDS, HADS-A and CES-D.

Authors:  Hanna Margaretha Heller; Stasja Draisma; Adriaan Honig
Journal:  Int J Environ Res Public Health       Date:  2022-06-21       Impact factor: 4.614

2.  Psychometric properties of the Urdu version of the Hospital Anxiety and Depression Scale (HADS) among pregnant women in Abbottabad, Pakistan.

Authors:  Fahad Saqib Lodhi; Aymen M Elsous; Saadia Irum; Adeel Ahmed Khan; Unaib Rabbani
Journal:  Gen Psychiatr       Date:  2020-08-24

3.  Factor structure and psychometric properties of english and spanish versions of the edinburgh postnatal depression scale among Hispanic women in a primary care setting.

Authors:  Chelsey M Hartley; Nicole Barroso; Yasmin Rey; Jeremy W Pettit; Daniel M Bagner
Journal:  J Clin Psychol       Date:  2014-05-07

4.  The correlation between postpartum depression and health status.

Authors:  Carlos Zubaran; Katia Foresti; Marina Verdi Schumacher; Aline Luz Amoretti; Mariana Rossi Thorell; Lúcia Cristina Müller
Journal:  Matern Child Health J       Date:  2010-09

Review 5.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

6.  Reliability and validity of the Ethiopian version of the hospital anxiety and depression scale (HADS) in HIV infected patients.

Authors:  Ayalu Aklilu Reda
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

7.  An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer.

Authors:  Jacqui Rodgers; Colin R Martin; Rachel C Morse; Kate Kendell; Mark Verrill
Journal:  Health Qual Life Outcomes       Date:  2005-07-14       Impact factor: 3.186

8.  Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients.

Authors:  Jürgen Barth; Colin R Martin
Journal:  Health Qual Life Outcomes       Date:  2005-03-16       Impact factor: 3.186

9.  Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women.

Authors:  Maki Ogawa; Yuichiro Watanabe; Takaharu Motegi; Naoki Fukui; Koyo Hashijiri; Ryusuke Tsuboya; Takuro Sugai; Jun Egawa; Rie Araki; Kazufumi Haino; Masayuki Yamaguchi; Koji Nishijima; Takayuki Enomoto; Toshiyuki Someya
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-26       Impact factor: 2.570

Review 10.  Measuring perinatal mental health risk.

Authors:  M Johnson; V Schmeid; S J Lupton; M-P Austin; S M Matthey; L Kemp; T Meade; A E Yeo
Journal:  Arch Womens Ment Health       Date:  2012-08-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.